SI van Leuven (@sivanleuven) 's Twitter Profile
SI van Leuven

@sivanleuven

Consultant Rheumatologist @Radboudumc with a special interest in cardio-rheumatology, Systemic Lupus Erythematosus and Systemic Sclerosis.

ID: 856083416642670592

calendar_today23-04-2017 09:52:46

118 Tweet

113 Followers

87 Following

SI van Leuven (@sivanleuven) 's Twitter Profile Photo

Outstanding presentation by professor Urowitz Lupus Academy on the past, present and future of #cardiovascular risk management in #SLE. Be aware of subclinical #atherosclerosis. #LupusAcademy24 #lupus #Rheumatology

Outstanding presentation by professor Urowitz <a href="/LupusAcademy/">Lupus Academy</a> on the past, present and future of #cardiovascular risk management in #SLE. Be aware of subclinical #atherosclerosis.
#LupusAcademy24 #lupus
#Rheumatology
Karen Schreiber (@karens_ldn) 's Twitter Profile Photo

♥Interested in #cardiovascular risk in #rheumatology? Experience in #inflammatory diseases?   Help us by participating in an international survey on awareness of @eular_orgguidelines (10 min)   🔗bit.ly/4gjx01C

♥Interested in #cardiovascular risk in #rheumatology? Experience in #inflammatory diseases? 
 
Help us by participating in an international survey on awareness of @eular_orgguidelines (10 min)
 
🔗bit.ly/4gjx01C
Alessia Alunno (@alessia_alunno) 's Twitter Profile Photo

📢 A EULAR study group project! Are you a person living with a #rheumatic and musculoskeletal disease? Share your thoughts on #cardiovascular prevention in this 15-min survey. s2survey.net/rmd_cardio/ Languages: 🇬🇧🇮🇹🇪🇸🇫🇷🇩🇪🇵🇹🇭🇺 🇩🇰🇳🇱 Thank you!

SI van Leuven (@sivanleuven) 's Twitter Profile Photo

Great study by Maria Tektonidou in @ACR_journals. Meeting targets of traditional risk factors (e.g. #cholesterol, BP) and remission of #SLE disease activity significantly attenutate the increased #CVD risk in #Lupus during 10 year followup! #cardiorheum acrjournals.onlinelibrary.wiley.com/doi/10.1002/ar…

Laurent ARNAUD (@lupusreference) 's Twitter Profile Photo

✅ Today is the perfect day to test your essential #Lupus knowledge with #SLAKE ⬇️ We are already taking into account the feedback received and preparing a v2.0 with more languages and the responses shown 👍

SI van Leuven (@sivanleuven) 's Twitter Profile Photo

Magnificent to have a #CardioRheum session at #BSR25! CVD risk remains high in #fheumatology, algorithms underestimate true risk but sensatie CV imaging could support early detection. BSR #Lupus #SSc #rheumatoidarthritis

Magnificent to have a #CardioRheum session at #BSR25! CVD risk remains high in #fheumatology, algorithms underestimate true risk but sensatie CV imaging could support early detection.
<a href="/RheumatologyUK/">BSR</a> #Lupus #SSc #rheumatoidarthritis
Laurent ARNAUD (@lupusreference) 's Twitter Profile Photo

✅ Do you have #LUPUS and #BRAINFOG? If so, we would like to INVITE YOU to contribute to our research STUDY for the development of the Lupus Brain Fog Severity Scale - a questionnaire to assess the characteristics and severity of brainfog in lupus 🦋 LINK:lupusresearch.limequery.org/697679?lang=en

✅ Do you have #LUPUS and #BRAINFOG? If so, we would like to INVITE YOU to contribute to our research STUDY for the development of the Lupus Brain Fog Severity Scale - a questionnaire to assess the characteristics and severity of brainfog in lupus 🦋
LINK:lupusresearch.limequery.org/697679?lang=en
SI van Leuven (@sivanleuven) 's Twitter Profile Photo

Judging by the amazing view from the roof of our hotel it looks like a great day to get #EULAR2025 going! #Rheumatology #RheumTwitter

Judging by the amazing view from the roof of our hotel it looks like a great day to get #EULAR2025 going! #Rheumatology #RheumTwitter
SI van Leuven (@sivanleuven) 's Twitter Profile Photo

Full house and really impressive results with CAR-T cell therapy in now 27 patients with refractory #Lupus (92% remission). Hopefully these extraordinary results can be reproduced in a larger trial. #EULAR2025 #Rheumatology #RheumTwitter

Full house and really impressive results with CAR-T cell therapy in now 27 patients with refractory #Lupus (92% remission). Hopefully these extraordinary results can be reproduced in a larger trial. #EULAR2025 #Rheumatology #RheumTwitter
SI van Leuven (@sivanleuven) 's Twitter Profile Photo

Great first day at #EULAR2025 by EULAR. Very excited to discuss our data on the perspective of patients and rheumatologists on cardiovascular risk management. #rheumatoidarthritis #Lupus #rheumatology #cardiorheum

Great first day at #EULAR2025 by <a href="/eular_org/">EULAR</a>. Very excited to discuss our data on the perspective of patients and rheumatologists on cardiovascular risk management. #rheumatoidarthritis #Lupus #rheumatology #cardiorheum
SI van Leuven (@sivanleuven) 's Twitter Profile Photo

Very interesting Hot topics in cardio-rheumatology session at #EULAR2025 with prof. Nurmohamed, Atzeni and Alunno. Risk management guidelines are available, implementation stays behind. Discussed strategies to improve this. #CardioRheum #Lupus #rheumatoidarthritis

Very interesting Hot topics in cardio-rheumatology session at #EULAR2025 with prof. Nurmohamed, Atzeni and Alunno. Risk management guidelines are available, implementation stays behind. Discussed strategies to improve this. #CardioRheum #Lupus #rheumatoidarthritis
SI van Leuven (@sivanleuven) 's Twitter Profile Photo

Very excited to discuss #atherosclerosis and #cardiovascular disease in #Rheumatology at #EULAR2025. Patients with #Lupus and #rheumatoidarthritis may be prone to develop plaque erosion. #CardioRheum #RheumTwitter

Very excited to discuss #atherosclerosis and #cardiovascular disease in #Rheumatology at #EULAR2025. Patients with #Lupus and #rheumatoidarthritis may be prone to develop plaque erosion. #CardioRheum #RheumTwitter
SI van Leuven (@sivanleuven) 's Twitter Profile Photo

Magnificent session on the rigorous process to formulate recommendations for challenging manifestations in #Lupus at #EULAR25.

Magnificent session on the rigorous process to formulate recommendations for challenging manifestations in #Lupus at #EULAR25.
SI van Leuven (@sivanleuven) 's Twitter Profile Photo

#Pericarditis has a high recurrence rate in #Lupus (20%), especially in younger patients (<40yrs). Use of prednisone >20mg is associated with a high recurrence rate, in a dose-dependent matter. Yet another reason to limit GC exposure. #EULAR2025 #CardioRheum

#Pericarditis has a high recurrence rate in #Lupus (20%), especially in younger patients (&lt;40yrs). Use of prednisone &gt;20mg is associated with a high recurrence rate, in a dose-dependent matter. Yet another reason to limit GC exposure. #EULAR2025 #CardioRheum